Shukra Pharmaceuticals Rights Issue

Shukra Pharmaceuticals Rights Issue

Shukra Pharmaceuticals Rights Issue will open for subscription from 15 February 2023. the company aims for an issue size of ₹18.79 Crores through this rights Issue.


About the company

Shukra Pharmaceuticals Limited is engaged in the field of Pharmaceuticals. They started their operations with a fully integrated plant in Rakanpor in Kalol, Gandhinagar – Gujarat. Even since its incorporation, the company has grown to immense heights in terms of operations and has expanded largely. Today, they have an internationally accredited Laboratory in Ahmedabad for creating each product on the highest quality standards.

Shukra Pharmaceuticals undertake operations including-

  • Contract Manufacturing
  • Loan License
  • Domestic and International Operations

The team of research analysts, medical officers, and technical experts of Shukra Pharmaceuticals ensure quality in each product and follow stringent regulations to deliver the same.


Objectives of the Issue


Rights Issue Timetable

Record Date02 February 2023
Credit of Rights Entitlements
Bid/Offer Opens On15 February 2023
Renunciation of Rights Entitlements
Bid/Offer Closes On28 February 2023
Deemed Date of Allotment
Credit Date
Listing Date

Shukra Pharmaceuticals Rights Issue Details

Issue OpenFeb 15, 2023 – Feb 28, 2023
Security NameShukra Pharmaceuticals Limited
Issue Size (Shares)9,394,050
Issue Size (Amount)₹18.79 Crores
Issue Price₹20 per share
Face Value₹10 per share
Listing AtBSE
Terms of PaymentRs. 5 per Rights Equity Share to be paid on Application and balance to be paid in three calls as determined.
Entitlement6 Equity Shares for every 1 Fully Paid Equity Share held

Company Financials

Period EndedTotal AssetsTotal RevenueProfit After Tax
31-Mar-2135.6111.550.19
31-Mar-2235.1120.570.75
(Amount in ₹ Crore)

Lead Manager(s)


Rights Issue Registrar


Company Contact Information

Shukra Pharmaceuticals Limited
Veer House, 3rd Floor, Judges Bungalow Road,
Opp. WIAA Motor Training School,
Bodakdev, Ahmedabad- 380054

Phone: +91 79 48901030
Email: info@shukrapharmaceuticals.com
Websitehttp://www.shukrapharmaceuticals.com/#


Final Thoughts

Applying for the rights issue is purely a personal choice. make sure you make a detailed study about the company and rights issue before you make an investment decision.

Happy investing

Leave a Comment

Your email address will not be published. Required fields are marked *